GFPC
KRRO icon

Global Financial Private Client’s Korro Bio KRRO Stock Holding History

Global Financial Private Client’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1
Closed -$282 – 648
2021
Q3 		$282 Hold
1
– – ﹤0.01% 590
2021
Q2 		$370 Buy
+1
New +$488 ﹤0.01% 589
2021
Q1 		– Sell
-60
Closed -$106K – 580
2020
Q4 		$106K Hold
60
– – 0.08% 132
2020
Q3 		$59.6K Hold
60
– – 0.05% 169
2020
Q2 		$67.7K Hold
60
– – 0.06% 180
2020
Q1 		$44.9K Buy
60
+20
+50% +$21.6K 0.05% 218
2019
Q4 		$35.1K Buy
+40
New +$31.1K 0.03% 279

Other funds holding KRRO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
SDIC
South Dakota Investment Council Sioux Falls, South Dakota $5.24B AUM 22.1% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Global Financial Private Client's KRRO Position: Q4 2021 in Review

Global Financial Private Client sold out of Korro Bio (KRRO) in Q4 2021, closing a stake of 1 share — an estimated $282 sold.

Global Financial Private Client first reported a position in KRRO in Q4 2019 and held it in 7 quarters. The position peaked at $106K in Q4 2020. 82 funds tracked by Wall St. Rank hold KRRO as of Q4 2021.

  • Global Financial Private Client reported no remaining Korro Bio position as of Q4 2021 after selling out during the quarter.
  • Global Financial Private Client sold 1 Korro Bio share in Q4 2021, an estimated $282.
  • Global Financial Private Client first reported a position in Korro Bio in Q4 2019 and held it in 7 quarters.
  • Global Financial Private Client's Korro Bio position peaked at $106K in Q4 2020.
  • 82 funds tracked by Wall St. Rank held Korro Bio as of Q4 2021.

Based on Global Financial Private Client's 13F filing for Q4 2021, filed 16 May 2024.